<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02836210</url>
  </required_header>
  <id_info>
    <org_study_id>WEH IRB# 15-514</org_study_id>
    <nct_id>NCT02836210</nct_id>
  </id_info>
  <brief_title>27-gauge Vitrectomy Wound Integrity: a Prospective, Randomized Trial Comparing Angled Versus Straight Entry</brief_title>
  <official_title>27-gauge Vitrectomy Wound Integrity: a Prospective, Randomized Trial Comparing Angled Versus Straight Entry in Fluid-filled Vitrectomized Eyes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wills Eye</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wills Eye</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To prospectively compare clinical outcomes using straight (perpendicular) versus angled
      trocar insertion during 27 gauge pars plana vitrectomy surgery for epiretinal membrane

      Primary Endpoints:

      Sclerotomy suture rates and incidence of suture blebs at the end of 27 gauge MIVS.

      Secondary Endpoints:

      Rate of postoperative wound-related complications such as hypotony, choroidal detachments,
      endophthalmitis, and sclerotomy-related retinal tears with a minimum follow-up of 30 days.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Microincision vitrectomy surgery (MIVS) has largely replaced use of conventional, 20-gauge
      vitrectomy, offering more rapid visual recovery, decreased postoperative pain and
      inflammation, and reduced surgical time with use of smaller diameter instruments1. Most
      recently, 27 gauge vitrectomy instrumentation has been introduced2, offering an additional
      small gauge option to the currently available 23, 25, or 25+ gauge systems.

      Initial experience with small gauge MIVS yielded mixed results, with early reports noting
      increased rates of wound-related postoperative complications including hypotony, choroidal
      detachments, endophthalmitis, and sclerotomy-related retinal tears3,4. However, with more
      experience and instrument modifications, outcomes with MIVS improved1,3. In a 2010 Ophthalmic
      Technology Assessment report by the American Academy of Ophthalmology, outcomes of MIVS were
      found comparable to that of 20 gauge vitrectomy benchmarks5.

      Prior studies have established that a two-stage, angled incision results in improved wound
      integrity with 23, 25, and 25+ MIVS systems6,7, helping to prevent complications such as
      post-operative endophthalmitis and hypotony. However, in the two clinical series describing
      outcomes of 27 gauge MIVS, a one-stage, perpendicular wound construction was performed
      without complication in a series of 31 patients2,8. Thus far, direct comparison between wound
      construction techniques (one-stage, perpendicular or two-stage, angled) has not been
      evaluated.

      The purpose of this study is to prospectively compare clinical outcomes using straight,
      one-stage (perpendicular) versus angled, two-stage trocar insertion during 27 gauge minimally
      invasive vitrectomy surgery (MIVS). The design of the study will be a randomized, clinical
      trial. Primary outcomes will be sclerotomy suture rates and incidence of suture blebs at the
      end of 27 gauge MIVS surgery for epiretinal membrane and macular pucker indications (no air
      or gas tamponade). Secondary endpoints will include rate of postoperative wound-related
      complications such as hypotony, choroidal detachments, endophthalmitis, and
      sclerotomy-related retinal tears with a minimum of 30 days follow-up.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2015</start_date>
  <completion_date type="Actual">October 2016</completion_date>
  <primary_completion_date type="Actual">July 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of sclerotomy site suturing and suture bleb formation</measure>
    <time_frame>Minimum follow-up 30 days.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of post-operative, wound related complications</measure>
    <time_frame>Minimum follow-up of 30 days</time_frame>
    <description>Rate of complications including hypotony, choroidal detachment, and endophthalmitis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in mean intraocular pressure</measure>
    <time_frame>Minimum follow-up of 30 days</time_frame>
    <description>Measured in mm Hg by tonometry</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Epiretinal Membrane</condition>
  <arm_group>
    <arm_group_label>Angled incision</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients in this arm will undergo 27-gauge vitrectomy wound construction using angled (tunnel-like) incisions for trocar entry.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Straight Incision</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients in this arm undergo 27-gauge vitrectomy wound construction using straight (perpendicular) incisions for trocar entry.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>27-gauge vitrectomy wound construction</intervention_name>
    <description>Conventional, 3-port pars plana vitrectomy with membrane peeling is performed for epiretinal membrane indication. Angled and straight trocar entry will be directly compared.</description>
    <arm_group_label>Angled incision</arm_group_label>
    <arm_group_label>Straight Incision</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients older than 18 years old undergoing 27 gauge vitrectomy surgery with membrane
             peel for epiretinal membrane

          -  Willing and able to comply with clinic visits and study-related procedures

          -  Provide signed informed consent

        Exclusion Criteria:

          -  History of previous vitrectomy surgery in the study eye.

          -  History of previous ocular surgery other than cataract extraction in the study eye.

          -  Requirement of an air or gas (SF6, C3F8) bubble at the conclusion of 27 gauge MIVS
             surgery.

          -  Aphakia, ACIOL, unstable PCIOL, and/or lenticular or zonular instability.

          -  Glaucoma requiring IOP lowering medications.

          -  Pre-existing ocular inflammation/uveitis.

          -  Any concurrent intraocular condition in the study eye that, in the opinion of the
             investigator, could either require medical or surgical intervention during the 12 week
             study period to prevent or treat visual loss that might result from that condition.
             Examples include infectious conjunctivitis, keratitis, and/or scleritis.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carl D Regillo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wills Eye Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mid Atlantic Retina- Wills Eye Institute</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Thompson JT. Advantages and limitations of small gauge vitrectomy. Surv Ophthalmol. 2011 Mar-Apr;56(2):162-72. doi: 10.1016/j.survophthal.2010.08.003. Epub 2011 Jan 14. Review.</citation>
    <PMID>21236459</PMID>
  </reference>
  <reference>
    <citation>Oshima Y, Wakabayashi T, Sato T, Ohji M, Tano Y. A 27-gauge instrument system for transconjunctival sutureless microincision vitrectomy surgery. Ophthalmology. 2010 Jan;117(1):93-102.e2. doi: 10.1016/j.ophtha.2009.06.043. Epub 2009 Oct 31.</citation>
    <PMID>19880185</PMID>
  </reference>
  <reference>
    <citation>Spirn MJ. Comparison of 25, 23 and 20-gauge vitrectomy. Curr Opin Ophthalmol. 2009 May;20(3):195-9. doi: 10.1097/ICU.0b013e328329eaea. Review.</citation>
    <PMID>19390437</PMID>
  </reference>
  <reference>
    <citation>Chen E. 25-Gauge transconjunctival sutureless vitrectomy. Curr Opin Ophthalmol. 2007 May;18(3):188-93. Review.</citation>
    <PMID>17435424</PMID>
  </reference>
  <reference>
    <citation>Recchia FM, Scott IU, Brown GC, Brown MM, Ho AC, Ip MS. Small-gauge pars plana vitrectomy: a report by the American Academy of Ophthalmology. Ophthalmology. 2010 Sep;117(9):1851-7. doi: 10.1016/j.ophtha.2010.06.014. Review.</citation>
    <PMID>20816248</PMID>
  </reference>
  <reference>
    <citation>Rizzo S, Barca F, Caporossi T, Mariotti C. Twenty-seven-gauge vitrectomy for various vitreoretinal diseases. Retina. 2015 Jun;35(6):1273-8. doi: 10.1097/IAE.0000000000000545.</citation>
    <PMID>25946694</PMID>
  </reference>
  <reference>
    <citation>Gupta OP, Maguire JI, Eagle RC Jr, Garg SJ, Gonye GE. The competency of pars plana vitrectomy incisions: a comparative histologic and spectrophotometric analysis. Am J Ophthalmol. 2009 Feb;147(2):243-250.e1. doi: 10.1016/j.ajo.2008.08.025. Epub 2008 Oct 23.</citation>
    <PMID>18947818</PMID>
  </reference>
  <reference>
    <citation>Teixeira A, Rezende FA, Salaroli C, Souza N, Sousa BA, Allemann N. In vivo comparison of 23- and 25-gauge sutureless vitrectomy incision architecture using spectral domain optical coherence tomography. J Ophthalmol. 2013;2013:347801. doi: 10.1155/2013/347801. Epub 2013 Mar 4.</citation>
    <PMID>23533705</PMID>
  </reference>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 14, 2016</study_first_submitted>
  <study_first_submitted_qc>July 14, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 18, 2016</study_first_posted>
  <last_update_submitted>November 30, 2016</last_update_submitted>
  <last_update_submitted_qc>November 30, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 1, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Wills Eye</investigator_affiliation>
    <investigator_full_name>MidAtlantic Retina</investigator_full_name>
    <investigator_title>Dr. Carl D. Regillo, MD</investigator_title>
  </responsible_party>
  <keyword>27-gauge Pars plana vitrectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epiretinal Membrane</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <pending_results>
    <submitted>November 15, 2017</submitted>
    <returned>December 13, 2017</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

